scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0092-8674(00)80539-5 |
P698 | PubMed publication ID | 9288758 |
P2093 | author name string | The International FMF Consortium | |
P2860 | cites work | Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene | Q24298289 |
Identification of a mutation in the gene causing hyperkalemic periodic paralysis | Q24314688 | ||
Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression | Q24324732 | ||
Basic local alignment search tool | Q25938991 | ||
Evolutionary study of multigenic families mapping close to the human MHC class I region | Q28249974 | ||
Prediction of protein secondary structure at better than 70% accuracy | Q29547323 | ||
Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence | Q29547917 | ||
Combining evolutionary information and neural networks to predict protein secondary structure | Q29614392 | ||
A knowledge base for predicting protein localization sites in eukaryotic cells | Q29618927 | ||
Interpreting cDNA sequences: some insights from studies on translation | Q30004215 | ||
cDNA selection: efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments | Q33451156 | ||
rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1 | Q33567423 | ||
A novel zinc finger coiled-coil domain in a family of nuclear proteins | Q34256632 | ||
The PROSITE database, its status in 1997. | Q34622236 | ||
Non-globular domains in protein sequences: automated segmentation using complexity measures | Q36726009 | ||
The region surrounding the PKD1 gene: a 700-kb P1 contig from a YAC-deficient interval | Q36822109 | ||
Exon amplification: a strategy to isolate mammalian genes based on RNA splicing | Q37506407 | ||
Circulating hydroxy fatty acids in familial Mediterranean fever | Q37678523 | ||
Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3. | Q38345910 | ||
Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel | Q38961469 | ||
Familial Mediterranean fever. A survey of 470 cases and review of the literature | Q40051008 | ||
Construction of a 1-Mb restriction-mapped cosmid contig containing the candidate region for the familial Mediterranean fever locus (MEFV) on chromosome 16p 13.3. | Q40650630 | ||
The gene causing familial Mediterranean fever maps to the short arm of chromosome 16 in Druze and Moslem Arab families | Q40694233 | ||
Autosomal dominant 'Mediterranean fever' in a Finnish family | Q40728814 | ||
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. | Q40732764 | ||
Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency | Q40770339 | ||
Plasma dopamine beta-hydroxylase: rapid diagnostic test for recurrent hereditary polyserositis | Q40781360 | ||
Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis | Q40791565 | ||
C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever | Q40825352 | ||
The cloning and characterization of a maternally expressed novel zinc finger nuclear phosphoprotein (xnf7) in Xenopus laevis | Q48201704 | ||
Evidence of changes in protease sensitivity and subunit exchange rate on DNA binding by C/EBP. | Q54317767 | ||
B30.2-like domain proteins: a growing family | Q73442902 | ||
Dominant inheritance in two families with familial Mediterranean fever (FMF) | Q95806382 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | familial Mediterranean fever | Q1144618 |
P304 | page(s) | 797-807 | |
P577 | publication date | 1997-08-01 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium | |
P478 | volume | 90 |
Q33599350 | 1Novel MEFV transcripts in Familial Mediterranean fever patients and controls |
Q40175789 | 30 years hids-Travels between bedside and bench |
Q55083339 | A Case of Familial Mediterranean Fever with Extensive Lymphadenopathy and Complex Heterozygous Genotype Presenting in the Fourth Decade. |
Q40141451 | A brief history of familial Mediterranean fever |
Q40542578 | A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations |
Q40372185 | A case of familial Mediterranean fever associated with compound heterozygosity for the pyrin variant L110P-E148Q/M680I in Japan |
Q61775115 | A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis |
Q35638094 | A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients |
Q40565375 | A founder effect in the hyperimmunoglobulinemia D and periodic fever syndrome |
Q40564787 | A large kindred with familial cold autoinflammatory syndrome |
Q40386324 | A monoallelic double mutation as a cause for TNF receptor-associated periodic fever syndrome |
Q39003335 | A motive for killing: effector functions of regulated lytic cell death. |
Q24300765 | A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta |
Q38693064 | A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy |
Q21261477 | A novel insertion mutation identified in exon 10 of the MEFV gene associated with Familial Mediterranean Fever |
Q40584548 | A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever |
Q40446212 | A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype. |
Q35823352 | A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome |
Q33871994 | A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome |
Q40382442 | A population genetics study of the familial Mediterranean fever gene: evidence of balancing selection under an overdominance regime |
Q40604151 | A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). |
Q35548982 | A survey of phenotype II in familial Mediterranean fever. |
Q38773387 | A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner |
Q40434545 | A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients |
Q40426013 | ABCC6 is unlikely to be a modifier gene for familial Mediterranean fever severity |
Q24298063 | ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis |
Q22010808 | ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells |
Q40460385 | ASC-mediated NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP. |
Q40604912 | Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever |
Q36017329 | Abdominal pain, arthritis, and nephrotic syndrome in a Syrian patient |
Q35671251 | Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β. |
Q35617506 | Accelerated apoptosis of neutrophils in familial mediterranean Fever. |
Q34608120 | Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy |
Q38693562 | Alternatively spliced MEFV transcript lacking exon 2 and its protein isoform pyrin-2d implies an epigenetic regulation of the gene in inflammatory cell culture models |
Q40223693 | Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study |
Q24623012 | Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects |
Q35550032 | Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene |
Q34115528 | Amyloidosis of familial mediterranean fever and the MEFV gene |
Q40589187 | An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome |
Q39126636 | An Up-to-date Approach to a Patient with a Suspected Autoinflammatory Disease |
Q24606097 | An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist |
Q40533811 | An improved electronic microarray-based diagnostic assay for identification of MEFV mutations |
Q52850152 | An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum. |
Q34978343 | An updated view on the structure and function of PYRIN domains |
Q33984080 | Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever |
Q40429804 | Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever |
Q96817025 | Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis |
Q40191340 | Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis |
Q47093501 | Applications of reconstituted inflammasomes in a cell-free system to drug discovery and elucidation of the pathogenesis of autoinflammatory diseases. |
Q42375802 | Approach to recurrent fever in childhood |
Q40348520 | Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. |
Q40243529 | As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio |
Q35983351 | Assessment of MEFV Gene Mutations in Exon 10 in Familial Mediterranean Fever Patients from Iranian Azeri and Turkish Population |
Q40123745 | Association Between Vitamin D Receptor Polymorphism and Familial Mediterranean Fever Disease in Turkish Children |
Q35692083 | Association between MEFV Mutations M694V and M680I and Behçet's Disease: A Meta-Analysis |
Q40248200 | Association between MEFV gene mutations and recurrent aphthous stomatitis in a cohort of Turkish patients |
Q60955507 | Association between MEFV polymorphisms and the susceptibility to ankylosing spondylitis in a Chinese Han population: A case-control study |
Q40306826 | Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey |
Q40573796 | Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis |
Q34326177 | Autoimmunity and apoptosis: the Crohn's connection |
Q38845301 | Autoinflammation and HLA-B27: Beyond Antigen Presentation |
Q34369278 | Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses |
Q35558406 | Autoinflammation: translating mechanism to therapy |
Q37048084 | Autoinflammatory Skin Disorders: The Inflammasomme in Focus |
Q38715104 | Autoinflammatory Syndromes in Children |
Q36520994 | Autoinflammatory disease reloaded: a clinical perspective |
Q40322564 | Autoinflammatory diseases as cause of wound healing defects |
Q36716818 | Autoinflammatory diseases: clinical and dermatologic features, genetics, pathogenesis and therapy. |
Q38959075 | Autoinflammatory diseases: update on classification diagnosis and management |
Q40323762 | Autoinflammatory syndromes |
Q36922302 | Autoinflammatory syndromes with a dermatological perspective |
Q47434993 | Autophagy dysfunction in autoinflammatory diseases |
Q28138106 | BSPRY, a novel protein of the Ro-Ret family |
Q26776123 | Bacterial Exotoxins and the Inflammasome |
Q40621738 | Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases |
Q24671543 | Behçet's disease: from Hippocrates to the third millennium |
Q27011650 | Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence |
Q34775451 | Bioactive proteins from stonefish venom |
Q31068003 | Bone mineral density in children with familial Mediterranean fever |
Q73061553 | Breakthroughs in the genetics of hereditary fevers |
Q36405072 | CATERPILLERs, pyrin and hereditary immunological disorders |
Q40209256 | Can colchicine response be predicted in familial Mediterranean fever patients? |
Q40089782 | Canakinumab Investigated for Treating Familial Mediterranean Fever |
Q38865019 | Canakinumab for the treatment of familial Mediterranean fever. |
Q49950020 | Canakinumab treatment in children with familial Mediterranean fever: report from a single center |
Q37737818 | Carbon monoxide decreases interleukin-1β levels in the lung through the induction of pyrin |
Q47672352 | Cardiovascular disease in patients with autoinflammatory syndromes |
Q101038925 | Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis |
Q33149792 | Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever |
Q34520488 | Caspase-1 regulates autoinflammation in rheumatic diseases |
Q37094016 | Caspases as therapeutic targets. |
Q42689576 | Caspy, a zebrafish caspase, activated by ASC oligomerization is required for pharyngeal arch development |
Q33785434 | Characterization of a core fragment of the rhesus monkey TRIM5α protein |
Q39877055 | Characterization of new mutations in the 5'-flanking region of the familial Mediterranean fever gene. |
Q24298360 | Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes |
Q37808103 | Chronic inflammation in FMF: markers, risk factors, outcomes and therapy |
Q42386239 | Chronic myelomonocytic leukemia as a cause of fatal uncontrolled inflammation in familial Mediterranean fever |
Q40559721 | Cisplatin Treatment Triggers Familial Mediterranean Fever Attacks |
Q38373888 | Clinical Review: Familial Mediterranean Fever-An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment. |
Q24300638 | Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations |
Q74590267 | Clinical differences between North African and Iraqi Jews with familial Mediterranean fever |
Q36603948 | Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein |
Q37898725 | Clinical immunology review series: An approach to the patient with a periodic fever syndrome. |
Q40062051 | Clinical update on inflammasomopathies |
Q40625160 | Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitis |
Q24293494 | Cloning and characterization of a novel human SPRYD4 gene encoding a putative SPRY domain-containing protein |
Q77522009 | Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: a rare occurrence |
Q37493594 | Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study |
Q53352157 | Colchicine: 1998 update. |
Q36384995 | Colchicine: old and new |
Q40356422 | Common MEFV mutation analysis in 36 Iranian patients with familial Mediterranean fever: clinical and demographic significance. |
Q39143373 | Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state |
Q40561053 | Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients |
Q92644003 | Comparable type I interferon score determination from PAXgene and Tempus whole blood RNA collection and isolation systems |
Q40442722 | Compound heterozygosity for three common MEFV mutations in a highly consanguineous family with familial Mediterranean fever |
Q45947333 | Comprehensive analysis of mutations in the MEFV gene reveal that the location and not the substitution type determines symptom severity in FMF. |
Q40273387 | Concomitance of Gitelman syndrome and familial Mediterranean fever: a rare case presentation |
Q22008521 | Construction of an approximately 700-kb transcript map around the familial Mediterranean fever locus on human chromosome 16p13.3 |
Q40552171 | Contribution of recent physiopathogenic progresses to the diagnosis of recurrent fevers |
Q40394627 | Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. |
Q37688957 | Cryopyrin-associated periodic syndromes: background and therapeutics |
Q35682403 | Crystal structure of TRIM20 C-terminal coiled-coil/B30.2 fragment: implications for the recognition of higher order oligomers |
Q92667909 | Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network Survey |
Q21092361 | DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer |
Q24337040 | De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases |
Q35553801 | Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever |
Q47663111 | Decreased serum vitamin B12 and vitamin D levels affect sleep quality in children with familial Mediterranean fever. |
Q39045378 | Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations |
Q40337000 | Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders |
Q37207033 | Developments in the scientific and clinical understanding of autoinflammatory disorders |
Q37840999 | Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic |
Q33891976 | Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations |
Q38745967 | Differential Expression of miR-4520a Associated With Pyrin Mutations in Familial Mediterranean Fever (FMF). |
Q28396225 | Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes |
Q36110186 | Diffuse and multifocal nephrogenic adenoma with Familial Mediterranean Fever: a case report with molecular study |
Q40087177 | Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants |
Q40225567 | Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis? |
Q37919837 | Does this patient have periodic fever syndrome? |
Q35555482 | E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever |
Q40533063 | E148Q/M694I mutation in 3 Japanese patients with familial Mediterranean fever |
Q26775286 | EULAR recommendations for the management of familial Mediterranean fever |
Q40478988 | Early and severe amyloidosis in a patient with concurrent familial Mediterranean fever and pseudoxanthoma elasticum. |
Q97420799 | Editorial: Autoinflammatory Diseases: From Genes to Bedside |
Q40053587 | Efficacy and safety analysis of off-label treatment with biologics in autoinflammatory diseases : Experiences from a German registry (GRAID2) |
Q33367939 | Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition |
Q40588018 | Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever |
Q44664107 | Enterophilin-1 interacts with focal adhesion kinase and decreases beta1 integrins in intestinal Caco-2 cells. |
Q30661538 | Enterophilins, a new family of leucine zipper proteins bearing a b30.2 domain and associated with enterocyte differentiation |
Q40606624 | Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states |
Q39829020 | Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. |
Q48266470 | Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes |
Q40343268 | Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype |
Q40171678 | Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers |
Q38335115 | Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever |
Q23915778 | Exposure in vivo to silica or lipopolysaccharide produces transient or sustained upregulation, respectively, of PYPAF7 and MEFV genes in bronchoalveolar lavage cells in rats |
Q40329881 | Expression of CD64 on polymorphonuclear neutrophils in patients with familial Mediterranean fever |
Q40257854 | Extensive thrombosis in a patient with familial Mediterranean fever, despite hyperimmunoglobulin D state in serum. [corrected]. |
Q40266303 | Familial Mediterranean Fever -- an increasingly important childhood disease in Sweden |
Q64292449 | Familial Mediterranean Fever Gene Mutations and Gout as an Auto-Inflammatory Arthropathy |
Q35777898 | Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy |
Q92796536 | Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans |
Q37716794 | Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management |
Q40590659 | Familial Mediterranean Fever: association of elevated IgD plasma levels with specific MEFV mutations |
Q28183734 | Familial Mediterranean fever |
Q40599060 | Familial Mediterranean fever |
Q74309346 | Familial Mediterranean fever |
Q74630068 | Familial Mediterranean fever |
Q40552834 | Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. |
Q40483124 | Familial Mediterranean fever and growth: effect of disease severity and colchicine treatment. |
Q35143035 | Familial Mediterranean fever and its implications for fertility and pregnancy. |
Q36170819 | Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature |
Q37892998 | Familial Mediterranean fever and seronegative arthritis. |
Q40613653 | Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients |
Q40183014 | Familial Mediterranean fever associated with MEFV mutations in a large cohort of Cypriot patients |
Q40619058 | Familial Mediterranean fever diagnosed by PCR. |
Q43725082 | Familial Mediterranean fever diagnostic criteria: comment on the article by Livneh et al. |
Q35580006 | Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease |
Q40428734 | Familial Mediterranean fever gene and protection against asthma |
Q40364188 | Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey |
Q40427320 | Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features |
Q40268824 | Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk |
Q40277153 | Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population |
Q40195639 | Familial Mediterranean fever in Syrian children: phenotype-genotype correlation. |
Q39998321 | Familial Mediterranean fever in Syrian patients: MEFV gene mutations and genotype-phenotype correlation |
Q40254151 | Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children? |
Q40431348 | Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations |
Q39368171 | Familial Mediterranean fever in two Bedouin families: mutation analysis and disease severity |
Q40567503 | Familial Mediterranean fever is no longer a rare disease in Italy |
Q40515284 | Familial Mediterranean fever mimicking septic arthritis |
Q47638843 | Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. |
Q37515104 | Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation |
Q40095229 | Familial Mediterranean fever patients homozygous for E148Q variant. |
Q37366257 | Familial Mediterranean fever with a single MEFV mutation: where is the second hit? |
Q31028353 | Familial Mediterranean fever with amyloidosis associated with novel exon 2 mutation (S1791) of the MEFV gene |
Q35225591 | Familial Mediterranean fever without MEFV mutations: a case-control study |
Q40241969 | Familial Mediterranean fever without fever as a cause of monoarthritis |
Q40499446 | Familial Mediterranean fever, clinical and laboratory findings |
Q24799138 | Familial Mediterranean fever, inflammation and nephrotic syndrome: fibrillary glomerulopathy and the M680I missense mutation |
Q39380468 | Familial Mediterranean fever, review of the literature. |
Q37847929 | Familial Mediterranean fever--a review |
Q40074680 | Familial Mediterranean fever-associated diseases in children. |
Q90009463 | Familial Mediterranean fever-associated infertility and underlying factors |
Q40296213 | Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis |
Q53649569 | Familial Mediterranean fever. |
Q40627280 | Familial Mediterranean fever. New aspects with respect to molecular genetics and pathogenesis revealed in three case reports |
Q37296449 | Familial Mediterranean fever: An updated review |
Q98188504 | Familial Mediterranean fever: Penetrance of the p.[Met694Val];[Glu148Gln] and p.[Met694Val];[=] genotypes |
Q26751292 | Familial Mediterranean fever: current perspectives |
Q45091232 | Familial Mediterranean fever: discovery of the responsible gene and the implications |
Q36247836 | Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients |
Q40267495 | Familial Mediterranean fever: the first adult case in Korea |
Q41751840 | Familial Mediterranean fever: the genetics of inflammation |
Q43870675 | Familial Mediterranean fever: the potential for misdiagnosis of E148V using the E148Q usual RFLP detection method. |
Q40583682 | Familial Mediterranean fever: the segregation of four different mutations in 13 individuals from one inbred family: genotype-phenotype correlation and intrafamilial variability. |
Q40111903 | Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. |
Q40320219 | Familial mediterranean Fever and hypercoagulability |
Q38727922 | Familial mediterranean Fever: diagnosing as early as 3 months of age. |
Q36431512 | Familial mediterranean fever in Arabs. |
Q38151758 | Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder |
Q34197548 | Familial mediterranean fever: revisiting an ancient disease |
Q32143337 | Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene |
Q39650247 | Frequency of inherited variants in the MEFV gene in myelodysplastic syndrome and acute myeloid leukemia |
Q40352499 | From hereditary recurrent fevers to autoinflammatory syndromes: the contribution of genetics |
Q48284953 | Function and mechanism of the pyrin inflammasome |
Q47285901 | Function and regulation of IL-1α in inflammatory diseases and cancer |
Q31045397 | GNIP, a novel protein that binds and activates glycogenin, the self-glucosylating initiator of glycogen biosynthesis |
Q35086225 | Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice |
Q38144090 | Gene hunting in autoinflammation |
Q97521393 | Gene-Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
Q74079811 | Genes with homology to mammalian apoptosis regulators identified in zebrafish |
Q38402415 | Genetic analysis of MEFV gene pyrin domain in patients with Behçet's disease |
Q37836189 | Genetic and molecular basis of inflammasome-mediated disease |
Q35019675 | Genetic clues to understanding periodic fevers, and possible therapies |
Q38734577 | Genetic epidemiology of Familial Mediterranean Fever through integrative analysis of whole genome and exome sequences from Middle East and North Africa |
Q33874070 | Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. |
Q34506303 | Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1β levels |
Q40264381 | Genetic methods for analysis of autoinflammatory diseases |
Q28268704 | Genetic risk factors of amyloidogenesis in familial Mediterranean fever |
Q33507084 | Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis |
Q38720044 | Genetically defined autoinflammatory diseases |
Q34360480 | Genetically determined recurrent fevers |
Q37897478 | Genetics of monogenic autoinflammatory diseases: past successes, future challenges |
Q36700670 | Genetics of the innate immune response in inflammatory bowel disease |
Q21283880 | Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties |
Q39436645 | Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases |
Q34362949 | Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations |
Q40626660 | Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis |
Q40358324 | Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations |
Q38746358 | Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review. |
Q54806502 | Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. |
Q35907740 | Global epidemiology of Familial Mediterranean fever mutations using population exome sequences. |
Q36823752 | Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction |
Q28243289 | Hereditary auto-inflammatory disorders and biologics |
Q40287804 | Hereditary autoinflammatory syndromes: a Brazilian multicenter study. |
Q31121756 | Hereditary immunologic disorders caused by pyrin and cryopyrin |
Q40530243 | Hereditary periodic fever |
Q24329184 | Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes |
Q35163232 | High Frequency of Inherited Variants in the MEFV Gene in Acute Lymphocytic Leukemia |
Q40359750 | High frequency of MEFV gene mutations in patients with myeloid neoplasm |
Q37997663 | High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility? |
Q36903094 | High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection |
Q89819649 | Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases |
Q24631660 | Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) |
Q38120387 | How should we approach classification of autoinflammatory diseases? |
Q40570106 | Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept |
Q40322522 | Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever |
Q43972812 | I591T MEFV mutation in a Spanish kindred: is it a mild mutation, a benign polymorphism, or a variant influenced by another modifier? |
Q34262561 | IL-1 blockade in autoinflammatory syndromes |
Q40075783 | IL-1β and Caspase-1 Drive Autoinflammatory Disease Independently of IL-1α or Caspase-8 in a Mouse Model of Familial Mediterranean Fever |
Q38074355 | IL-1β biological treatment of familial Mediterranean fever. |
Q90011996 | IL1-blocking therapy in colchicine-resistant familial Mediterranean fever |
Q39790268 | INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations |
Q47987319 | Identification and characterization of a zinc finger gene (ZNF213) from 16p13.3. |
Q34146734 | Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever |
Q30668589 | Identification of multifaceted binding modes for pyrin and ASC pyrin domains gives insights into pyrin inflammasome assembly |
Q22004009 | Identification of two Krüppel-related zinc finger genes (ZNF200 and ZNF210) from human chromosome 16p13.3 |
Q40496667 | Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients |
Q40499847 | IgA nephropathy in an Italian child with familial Mediterranean fever. |
Q38259418 | Immunological function of familial Mediterranean fever disease protein Pyrin |
Q37979862 | Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. |
Q87431443 | In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up |
Q40254261 | Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype |
Q34141506 | Increased frequency of Mediterranean fever gene variants in multiple myeloma |
Q40481428 | Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? |
Q40236735 | Increased intracellular oxygen radical production in neutrophils during febrile episodes of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome |
Q40528366 | Infevers: an evolving mutation database for auto-inflammatory syndromes |
Q91711922 | Inflammasome Adaptor ASC Is Highly Elevated in Lung Over Plasma and Relates to Inflammation and Lung Diffusion in the Absence of Speck Formation |
Q96575977 | Inflammasome activation and regulation: toward a better understanding of complex mechanisms |
Q39044498 | Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). |
Q36829403 | Inflammasome-Mediated Autoinflammatory Disorders |
Q34905606 | Inflammasomes and their activation. |
Q90683704 | Inflammasomes in the pathophysiology of autoinflammatory syndromes |
Q40484897 | Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? |
Q38093826 | Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature |
Q57369432 | Inherited disorders of cholesterol biosynthesis |
Q28392019 | Inhibiting the inflammasome: one domain at a time |
Q38985852 | Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome |
Q89999182 | Insights into rheumatic diseases from next-generation sequencing |
Q28212112 | Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis |
Q34395848 | Interferon-inducible factor 16 is a novel modulator of glucocorticoid action |
Q39301613 | Interleukin-1 Blockade: An Update on Emerging Indications |
Q40376774 | Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation |
Q64275741 | Interleukin-18 in Health and Disease |
Q42109190 | Interleukin-1β inhibitors for the treatment of cryopyrin-associated periodic syndrome |
Q57688726 | Interventions for reducing inflammation in familial Mediterranean fever |
Q24187197 | Interventions for reducing inflammation in familial Mediterranean fever |
Q24201537 | Interventions for reducing inflammation in familial Mediterranean fever |
Q35637910 | Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever |
Q33514820 | Involvement of the modifier gene of a human Mendelian disorder in a negative selection process |
Q64884960 | Kawasaki disease and familial mediterranean fever gene mutations, is there any link? |
Q40572763 | Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome |
Q35078047 | Large pericardial effusion in a family with recurrent pericarditis: A report of probable x-linked transmission |
Q26827163 | Lighting the fires within: the cell biology of autoinflammatory diseases |
Q38657169 | Lights and shadows in autoinflammatory syndromes from the childhood and adulthood perspective |
Q40619053 | Liver and brain mucormycosis in a diabetic patient type II successfully treated with liposomial amphotericin B. |
Q43426439 | Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1/PSTPIP1 gene is associated with aseptic abscesses and with Crohn disease in French patients |
Q46158080 | M694V mutation may have a role in susceptibility to ankylosing spondylitis. |
Q38628638 | MEFV M694V mutation has a role in susceptibility to ankylosing spondylitis: A meta-analysis. |
Q40241499 | MEFV Variants in Patients with PFAPA Syndrome in Japan |
Q40317284 | MEFV gene mutation spectrum in familial Mediterranean fever (FMF) : a single center study in the Aegean region of Turkey |
Q40447308 | MEFV gene mutations spectrum among Lebanese patients referred for Familial Mediterranean Fever work-up: experience of a major tertiary care center. |
Q50122752 | MEFV gene testing may guide physicians for early diagnosis of familial Mediterranean fever |
Q40227432 | MEFV gene variations in patients with systemic lupus erythematosus |
Q40256420 | MEFV gene variations in patients with systemic lupus erythematosus |
Q58284002 | MEFV mutation analysis in Turkish familial Mediterranean fever patients with amyloidosis |
Q58273510 | MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever |
Q38987311 | MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations |
Q38901444 | MEFV mutations in Moroccan patients suffering from familial Mediterranean Fever |
Q40618094 | MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? |
Q40389450 | MEFV mutations in patients with Familial Mediterranean Fever from the Aegean region of Turkey. |
Q22010244 | MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development |
Q36566547 | Management of familial Mediterranean fever by colchicine does not normalize the altered profile of microbial long chain fatty acids in the human metabolome |
Q40637311 | Mechanisms for treatment: periodic disease |
Q40241017 | Mediterranean Fever gene analysis in the azeri turk population with familial mediterranean Fever: evidence for new mutations associated with disease |
Q40353369 | Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease |
Q40171401 | Mediterranean fever gene mutations: correlation with cytotoxic T-lymphocyte-associated antigen 4 gene polymorphism. |
Q36041225 | Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling |
Q37733733 | Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations. |
Q33798590 | Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals |
Q39301708 | Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient |
Q38211947 | Monogenic autoinflammatory diseases |
Q37162157 | Monogenic autoinflammatory diseases: concept and clinical manifestations |
Q37466515 | Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation |
Q34489840 | Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis |
Q37299354 | Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues |
Q89927186 | Moving towards a systems-based classification of innate immune-mediated diseases |
Q40227631 | Multiple myeloma occurring in a familial Mediterranean fever |
Q59336394 | Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan |
Q40599425 | Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population |
Q24291856 | Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome |
Q24308730 | Mutations in NALP12 cause hereditary periodic fever syndromes |
Q33864877 | Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. |
Q36912187 | NALP inflammasomes: a central role in innate immunity. |
Q28206764 | NALPs: a novel protein family involved in inflammation |
Q36944426 | NLR proteins: integral members of innate immunity and mediators of inflammatory diseases |
Q27642273 | NMR structure of the apoptosis- and inflammation-related NALP1 pyrin domain |
Q38242966 | NOD-like receptors interfacing the immune and reproductive systems. |
Q34199862 | NODs: intracellular proteins involved in inflammation and apoptosis |
Q38076049 | Negative regulation of human mononuclear phagocyte function |
Q33903590 | Neutrophils: molecules, functions and pathophysiological aspects |
Q47949775 | New insights into the epigenetics of inflammatory rheumatic diseases. |
Q38253392 | New players driving inflammation in monogenic autoinflammatory diseases |
Q40138574 | Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. |
Q38374152 | Non-canonical manifestations of familial Mediterranean fever: a changing paradigm |
Q35553949 | Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients |
Q52607184 | Novel aspects of the assembly and activation of inflammasomes with focus on the NLRC4 inflammasome. |
Q88990365 | Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases |
Q38122566 | Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics |
Q48277726 | One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study |
Q30424095 | Origin and diversification of TRIM ubiquitin ligases |
Q36762550 | Oscillations in the immune system |
Q34102054 | P wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany |
Q24292156 | PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B |
Q34560380 | Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes |
Q40239441 | Patient management and the association of less common familial Mediterranean fever symptoms with other disorders. |
Q37852153 | Periodic Peritonitis due to Familial Mediterranean Fever in a Patient with Systemic Lupus Erythematosus |
Q33866992 | Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome |
Q42786318 | Periodic fevers enter the era of molecular diagnosis |
Q38066272 | Phenotype 2 familial mediterranean fever: evaluation of 22 case series and review of the literature on phenotype 2 FMF. |
Q34086383 | Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features |
Q38866091 | Phenotype-genotype updates from familial Mediterranean fever database registry of Mansoura University Children' Hospital, Mansoura, Egypt |
Q40489339 | Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever |
Q34439639 | Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis. |
Q37721227 | Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra--case report and review |
Q29620319 | Points of control in inflammation |
Q73194010 | Polymorphisms in the MLL breakpoint cluster region (BCR) |
Q36849254 | Population genetics of familial Mediterranean fever: a review. |
Q39374120 | Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition. |
Q26767114 | Precision autophagy directed by receptor regulators - emerging examples within the TRIM family |
Q40173923 | Predictors of AA amyloidosis in familial Mediterranean fever. |
Q33363139 | Predominant role of host genetics in controlling the composition of gut microbiota |
Q40388867 | Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome |
Q40546130 | Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura |
Q36021488 | Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease |
Q40108750 | Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey |
Q89099575 | Prevalence of Mediterranean FeVer Gene Mutations in Turkish Cypriot Population |
Q34367330 | Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist |
Q35028758 | Profiles of Microbial Fatty Acids in the Human Metabolome are Disease-Specific. |
Q39064225 | Protein inhibitor of acid deoxyribonucleases. Improved purification procedure and properties |
Q40362651 | Protracted febrile myalgia syndrome in familial Mediterranean fever |
Q40140940 | Psoriasis-like lesions in a patient with familial Mediterranean fever |
Q34273588 | Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1 |
Q40473433 | Pulmonary amyloidosis in familial Mediterranean fever. |
Q47332836 | Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis |
Q33479535 | Pyrin Modulates the Intracellular Distribution of PSTPIP1. |
Q30489231 | Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants |
Q24655872 | Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway |
Q37661273 | Pyrin critical to macrophage IL-1beta response to Francisella challenge |
Q28596027 | Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS |
Q26827832 | Pyrin- and CARD-only Proteins as Regulators of NLR Functions |
Q40147075 | Pyrin-PSTPIP1 colocalises at the leading edge during cell migration |
Q40262692 | Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence |
Q90290826 | Recurrence of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome after tonsillectomy: case-based review |
Q38680309 | Recurrent Fevers for the Pediatric Immunologist: It's Not All Immunodeficiency |
Q37468460 | Recurrent febrile syndromes: what a rheumatologist needs to know |
Q28208176 | Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever |
Q28180120 | Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product |
Q26996605 | Regulation of inflammasome signaling |
Q36931677 | Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein, ASC. |
Q64989555 | Relapsing periodic arthritis, palindromic rheumatism and MEFV gene-related variants alleles in children. |
Q36324988 | Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? |
Q37371210 | Relationship between genetic mutation variations and acute-phase reactants in the attack-free period of children diagnosed with familial Mediterranean fever |
Q40138008 | Relationship between periodontal destruction and gene mutations in patients with familial Mediterranean fever. |
Q36851095 | Renal amyloidosis due to familial mediterranean fever misdiagnosed |
Q37848210 | Renal amyloidosis in children |
Q40064657 | Retinal and Choroidal Thickness in Adult Patients with Familial Mediterranean Fever. |
Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
Q36779478 | Ribotoxic stress through p38 mitogen-activated protein kinase activates in vitro the human pyrin inflammasome. |
Q40170055 | Risk factors for subclinical inflammation in children with Familial Mediterranean fever |
Q37822295 | Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis |
Q40070578 | Role of genetics in familial Mediterranean fever |
Q47138746 | Role of genetics in pediatric rheumatology |
Q92077069 | Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics |
Q40357744 | Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever |
Q24597380 | SMART, a simple modular architecture research tool: identification of signaling domains |
Q39262471 | Screening of common and novel familial mediterranean fever mutations in south-east part of Turkey. |
Q40413709 | Search for copy number alterations in the MEFV gene using multiplex ligation probe amplification, experience from three diagnostic centres |
Q40224961 | Self-medication to treat pain in attacks of familial Mediterranean fever: aiming to find a new approach to pain management |
Q40558606 | Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis |
Q40440510 | Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF-173G/C polymorphism |
Q40460104 | Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. |
Q35555791 | Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene |
Q37200090 | Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation |
Q40185834 | Sonographic assessment of spleen size in Turkish migrants with Familial Mediterranean fever in Germany |
Q35550749 | Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV |
Q24541987 | Structural and functional insights into the B30.2/SPRY domain. |
Q24684586 | Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function |
Q28652890 | Structural, expression, and evolutionary analysis of mouse CIAS1 |
Q36306733 | Suppression of cancer phenotypes through a multifunctional actin-binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion |
Q40384826 | Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) in siblings |
Q36927947 | Systemic Concentrations of Short Chain Fatty Acids Are Elevated in Salmonellosis and Exacerbation of Familial Mediterranean Fever |
Q35659928 | Systemic arthritis in children: a review of clinical presentation and treatment |
Q54123367 | TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. |
Q40191651 | TLR2 and TLR4 gene expression levels and associated factors during acute attack and attack-free periods in familial Mediterranean fever |
Q63976848 | TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy |
Q33971049 | TNFRSF1A mutations and autoinflammatory syndromes |
Q24607229 | TRIM family proteins and their emerging roles in innate immunity |
Q24338801 | TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity |
Q27650357 | TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved |
Q24294243 | TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation |
Q42520295 | TRIM9 is specifically expressed in the embryonic and adult nervous system |
Q40562330 | Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis |
Q35804717 | Targeting the inflammasome in rheumatic diseases. |
Q34684433 | The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production |
Q37270409 | The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases |
Q33932432 | The DAPIN family: a novel domain links apoptotic and interferon response proteins |
Q37848193 | The Eurofever Project: towards better care for autoinflammatory diseases |
Q40348928 | The Familial Mediterranean Fever Gene as a Modifier of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome |
Q36605185 | The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA. |
Q37689981 | The MEFV gene pathogenic variants and phenotype-genotype correlation in children with familial Mediterranean fever in the Çanakkale population |
Q40607611 | The MICA region determines the first modifier locus in familial Mediterranean fever |
Q35159220 | The MetaFMF website: a high quality tool for meta-analysis of FMF. |
Q38423379 | The NAIP-NLRC4 inflammasome in innate immune detection of bacterial flagellin and type III secretion apparatus |
Q36931672 | The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self |
Q30956847 | The PYRIN connection: novel players in innate immunity and inflammation |
Q28383855 | The PYRIN domain in signal transduction |
Q24644648 | The PYRIN domain: a member of the death domain-fold superfamily |
Q28206887 | The PYRIN domain: a novel motif found in apoptosis and inflammation proteins |
Q92921941 | The Pyrin Inflammasome in Health and Disease |
Q26749025 | The Relationship between NALP3 and Autoinflammatory Syndromes |
Q28179242 | The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif |
Q40146198 | The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing |
Q40337569 | The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues |
Q38349872 | The Tumor Necrosis Factor α-dependent Activation of the Human Mediterranean Fever (MEFV) Promoter Is Mediated by a Synergistic Interaction between C/EBPβ and NFκB p65 |
Q97518819 | The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review |
Q40363320 | The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children |
Q38967233 | The burgeoning field of innate immune-mediated disease and autoinflammation |
Q34464837 | The camptodactyly-arthropathy-coxa vara-pericarditis syndrome: clinical features and genetic mapping to human chromosome 1. |
Q40573334 | The changing aetiological spectrum of pericarditis in children |
Q57160539 | The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders |
Q40401212 | The clinical and genetical features of 124 children with Familial Mediterranean fever: experience of a single tertiary center |
Q34598115 | The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population |
Q40464864 | The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. |
Q40049239 | The detection of a novel insertion mutation in exon 2 of the MEFV gene associated with familial mediterranean fever in a moroccan family |
Q40282424 | The effect of colchicine on pyrin and pyrin interacting proteins |
Q34039381 | The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever |
Q38975015 | The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome |
Q40466570 | The expanded clinical spectrum of familial Mediterranean fever. |
Q33592763 | The expanding spectrum of rare monogenic autoinflammatory diseases |
Q39426709 | The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever |
Q40516407 | The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease |
Q24291475 | The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments |
Q24642151 | The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment |
Q84912459 | The frequency of MEFV gene mutations in Behcet's disease and their relation with clinical findings |
Q74744600 | The genetic etiology of systemic lupus erythematosus: a short dispatch from the combat zone |
Q27325503 | The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis |
Q24304087 | The inflammasomes |
Q37600652 | The inherited autoinflammatory syndrome: a decade of discovery. |
Q39443996 | The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation |
Q40601396 | The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease |
Q22008007 | The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant |
Q33465135 | The prevalence of celiac disease among patients with familial mediterranean Fever |
Q28204881 | The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation |
Q37903230 | The regulation of MEFV expression and its role in health and familial Mediterranean fever |
Q40497943 | The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients. |
Q36981046 | The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach |
Q40299613 | The role of regulatory T cells in familial Mediterranean fever (FMF). |
Q39646251 | The role of the pro-apoptotic protein Siva in the pathogenesis of Familial Mediterranean fever: A structural and functional analysis |
Q40267982 | The scintigraphic evaluation and genetic correlation of joint involvements in pediatric patients with familial Mediterranean fever |
Q78600172 | The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever |
Q34314032 | The spectrum of Familial Mediterranean Fever (FMF) mutations |
Q37208960 | The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies |
Q24291183 | The tripartite motif family identifies cell compartments |
Q24535763 | The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers |
Q34714963 | Thoracic and lung involvement in familial Mediterranean fever (FMF). |
Q90171023 | Toward targeting inflammasomes: insights into their regulation and activation |
Q58698926 | Towards personalized medicine in Ménière’s disease |
Q38202563 | Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases |
Q36501135 | Two Genetic Variations in the IRF8 region are associated with Behçet's disease in Han Chinese |
Q40551844 | Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment |
Q39525163 | Two novel mutations R653H and E230K in the Mediterranean fever gene associated with disease |
Q38004932 | Type I IFN-mediated regulation of IL-1 production in inflammatory disorders. |
Q91614231 | Ubiquitination-Mediated Inflammasome Activation during Bacterial Infection |
Q26749573 | Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever |
Q90727834 | Update on the management of colchicine resistant Familial Mediterranean Fever (FMF) |
Q40561366 | Urinary glycosaminoglycans in the course of familial Mediterranean fever |
Q34194218 | Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with Familial Mediterranean fever |
Q40310083 | Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. |
Q33650709 | Validation of the new paediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders |
Q34420031 | When less is more: primary immunodeficiency with an autoinflammatory kick |
Q24647356 | Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase |
Q38337492 | XL43 and XL75: two novel RING finger-containing genes expressed during oogenesis and embryogenesis in Xenopus laevis |
Q40478055 | [Auto-inflammatory disease with hyperimmunoglobulinemia D of late onset]. |
Q87893038 | [Autoinflammatory syndromes : Practical approach to diagnostics and therapy] |
Q83811771 | [Autoinflammatory syndromes] |
Q77421303 | [Familial mediterranean fever is a hereditary disorder of the neutrophil] |
Q77421317 | [Genetic diagnosis of periodic disease] |
Q74589977 | [Genetic diagnosis of periodic diseases (familial mediterranean fever or FMF)] |
Q87907460 | [Inflammasome and gout] |
Q40376766 | [Molecular diagnostics of hereditary fever syndromes. Familial Mediterranean fever (FMF), hyperimmunoglobulin D syndrome (HIDS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndrome (CAPS: FCAS, |
Q30852257 | bloodthirsty, an RBCC/TRIM gene required for erythropoiesis in zebrafish |
Q42375820 | Approche à la fièvre récurrente de l’enfant |
Search more.